Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV) (CYTO-PV)

This study has been terminated.
(Low accrual rate not allowing planned sample size leads to a futility condition)
Sponsor:
Collaborators:
Agenzia Italiana del Farmaco
A.O. Ospedale Papa Giovanni XXIII
Information provided by (Responsible Party):
Consorzio Mario Negri Sud
ClinicalTrials.gov Identifier:
NCT01645124
First received: July 17, 2012
Last updated: July 19, 2012
Last verified: May 2012